Krenn, M.* et al. Holistic exome-based genetic testing in adults with epilepsy. Neurol. Genet. 11:e200260 (2025)
Hildebrand, M.S.* et al. Inherited PURA pathogenic variant associated with a mild neurodevelopmental disorder. Neurol. Genet. 10:e200181 (2024)
Indelicato, E.* et al. New-onset refractory status epilepticus due to a novel MT-TF variant: Time for acute genetic testing before treatment? Neurol. Genet. 9:e200063 (2023)
Neuhofer, C.M.* et al. LINS1-associated neurodevelopmental disorder family with novel mutation expands the phenotypic spectrum. Neurol. Genet. 6:e500 (2020)
Radelfahr, F.* et al. Biotinidase deficiency: A treatable cause of hereditary spastic paraparesis. Neurol. Genet. 6:e525 (2020)
Stendel, C.* et al. Delineating MT-ATP6-associated disease. Neurol. Genet. 6:e393 (2020)
Johannesen, K.* et al. Defining and expanding the phenotype of QARS-associated developmental epileptic encephalopathy. Neurol. Genet. 5:e373 (2019)
Krenn, M.* et al. Adult-onset variant ataxia-telangiectasia diagnosed by exome and cDNA sequencing. Neurol. Genet. 5:e346 (2019)
Pulit, S.L.* et al. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes. Neurol. Genet. 4:e293 (2018)
Reinthaler, E.M.* et al. TPP2 mutation associated with sterile brain inflammation mimicking MS. Neurol. Genet. 4:e285 (2018)
Lesage, S.* et al. Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease. Neurol. Genet. 1:e9 (2015)